chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her daughter in law had third dose as well, and experienced itching in both eyes.; her daughter in law had third dose as well, and experienced itching in both eyes.; itching in her eyes; This is a spontaneous report from a contactable consumer via Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number was not reported),  via an unspecified route of administration on an unspecified date as dose 3, single for covid-19 immunization.  The patient medical history and concomitant medications were not reported.  Historical vaccine included BNT162B2 as dose 1,single and dose 2, single for covid-19 immunization. Patient experienced itching in both eyes a day after the third dose. She read to put ice on the eyes on internet because other people also experienced the same problem. Patient iced her eyes as well. The outcome of the event itching in her eyes was unknown.  The lot number for the vaccine BNT162B2, was not provided and will be requested during follow up.
Patient received Moderna vaccine on 5/18/21 in right deltoid and her muscle is still quite sore.  She is going to call her doctor Tuesday if it is still hurting
I have been experiencing tremendous pain during my menstrual cycles, something I didn?t experience  before.
sick 3-4 days; arm hurt; chills; This spontaneous case was reported by a health care professional and describes the occurrence of ILLNESS (sick 3-4 days), VACCINATION SITE PAIN (arm hurt) and CHILLS (chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     Concurrent medical conditions included Adhesive tape allergy (allergic to 3M Tegaderm transparent dressing.). Concomitant products included METOPROLOL SUCCINATE (TOPROL XL), HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (COZAAR COMP), FUROSEMIDE, GABAPENTIN (GABAPENTIN 2K), ALLOPURINOL (ALLOPURINOL BP), OMEPRAZOLE, EZETIMIBE (EZETIMIBE CF), FENOFIBRATE (FENOFIBRATE (II)), IPRATROPIUM, TESTOSTERONE CIPIONATE (TESTOSTERONE CYPIONATE), FLUTICASONE PROPIONATE (FLUTICASONE CIPLA), AZELASTINE HYDROCHLORIDE (ASTEPRO), CLONAZEPAM (KLONOPIN), FISH OIL (OMEGA 3 AGE DEFENCE), INSULIN HUMAN, INSULIN HUMAN INJECTION, ISOPHANE (HUMULINE), MONTELUKAST SODIUM (SINGULAIR BABY), ANASTROZOLE (ANASTROZOLE AN), LEVOTHYROXINE SODIUM (SYNTHROID), CARISOPRODOL (CARISOPRODOL ACTAVIS), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), PARACETAMOL (TYLENOL A), IBUPROFEN (IBUPROFEN 2CARE4), VITAMIN C [ASCORBIC ACID], MULTIVITAMINS [VITAMINS NOS], CINNAMOMUM CASSIA (CINNAMON [CINNAMOMUM CASSIA]), UBIDECARENONE (COQ 10), VITAMIN B COMPLEX (B COMPLEX (B50)), VITAMIN D3 and THIAMINE (VITAMIN B1 [THIAMINE]) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced ILLNESS (sick 3-4 days), VACCINATION SITE PAIN (arm hurt) and CHILLS (chills). At the time of the report, ILLNESS (sick 3-4 days), VACCINATION SITE PAIN (arm hurt) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant drugs also included 17gram of polyethylene glycol 3350 powder, MagniLlife muscle cramp pain reliever.  As per source document, patient had a broken back, gout arthritis, hands did not work very good and not allergic to any medicines.   This case was linked to MOD-2021-350577 (Patient Link).
Pt administered Fluarix brand flu vaccine in the right deltoid area on 1/29/07. Three days later she said that the area became reddened and "hard all around it for 5 days. She also stated that she had taken the flu vaccine annually for 10 years (unknown brand) and has had no problems except for the first year when she was sick for one month after taking the vaccine.
At 1545 - pt. called down from other building to say his "(L) hand felt heavy and that his (L) arm felt number and tingly". Denied pain, SOB, dizzy, denied rash. Had stated he had full ROM without difficulty other than numb/tingly. CDC was called. No allergic reaction -> by 1655 pt voice he "was fine".
Wife came in for second dose appointment and handed over husbands vaccination card. Wife reported patient died on Saturday after waking up in the morning and deciding to sleep in for a bit longer. She reported getting out of bed and he was breathing and when she went back to wake him up he wouldn't wake. She called 911 and he was pulseless, she reported emergency aid "Shocked him" and worked on him for 45 minutes before asking her for permission to stop. Site will destroy vaccine card as the wife did not wish to keep it.
Developed chills, sweating, body aches, exhaustion, Headache, swollen arm at site of injection and under the arm. Took 2 extra strength tylenol every 6 hours until symptoms were gone. Started 14 hours after the injection.  Felt better 40 hours after the injection.
This spontaneous report was received from a licensed practical nurse and refers to a 12-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-DEC-2017, the patient was vaccinated with a dose of GARDASIL 9 one single injection, lot# N020352 and expiration date: 10-APR-2020 (route of administration was not reported). The reporter denied any adverse effects.
Information has been received from a medical assistant referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant medication were not reported. On unknown dates, the patients were vaccinated with doses of improperly stored RECOMBIVAX HB (lot # L038018 with expiration date 13-SEP-201; lot # M006708 with expiration date 02-JUN-2018; lot # M010671 with expiration date 02-JUN-2018, lot # L030581 with expiration date 26-JUN-2017, strength, dose, frequency and route were not reported). No adverse effects were reported. This is one of three reports received from the same reporter. Additional information has been requested.
Swelling just under injection site with rash, redness and hot to the touch. Also a knot in neck on the same side as the injection site.
I was short of breath and went to emergency room on 1/5/2021.  I was diagnosed with bilateral pulmonary embolisms.  I was Covid negative and had no other symptoms.
Fatigue; Soreness in Injection Site; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 14Mar2021 at 17:45 (at the age of 58-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history and concomitant medications was not reported. The patient had a history of allergy to Penicillin and Sulfa. Prior to the vaccination, the patient was not diagnosed with Covid-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021, the patient experienced fatigue for next 2 days and had soreness in injection site. The patient did not receive any treatment for the adverse events. The clinical outcomes of fatigue and soreness in injection site was recovering.  Information about lot/batch number cannot be obtained. No further information is expected.
Painful left arm, unable to move, no swelling or redness.  Chills and body aches first 12 hours, arm pain continues with no ability to move.
AFTER ONE DOSE PATIENT HAD SEVERE GI DISTRESS, DIARRHEA, FOLLOWED BY 1 MONTH OF COUGH AND NEW LEFT HAND TREMOR.
Physician received a message from the health dept on 04/11/2002 stating that the pt had the chicken pox. Pt as brought in on 04/17/2002 and was diagnosed with URI and placed on amoxicillin. There was no mention of a rash.
This spontaneous report was received from 51 year old male patient (the pharmacist) who reported on himself. On 24-JUN-2014 the patient was vaccinated with a dose of ZOSTAVAX (dose and route not reported, lot # J011882, expiration date 04-JAN-2015). On an unknown date in 2014 the patient developed redness and pain, soreness at the injection site. The patient stated that the symptoms lasted for over a week. The patient was fully recovered as of 11-JUL-2014. The relatedness between the events and ZOSTAVAX was not reported. This is one of several reports from the same source. Additional information has been requested.
Patient reports experiencing fever and chills following the vaccination for which he took Tylenol. The fever only lasted 2-3 hours. Patient also reports rash on his injection arm. It started the following morning after vaccination and it began getting larger. Patient will seek doctor care if condition does not improve in 1 day.
The patient received  vaccine 12 days past the expiration date. The vaccine was in the refergiratior for 10 week and it was 12 days past that.
rapid heart beat; having stroke like symptoms; My left eye developed a blind spot; my balance and coordination are compromised; my balance and coordination are compromised; my speech and cognitive thinking is impaired; my speech and cognitive thinking is impaired; I am now acutely light sensitive; sometimes there is numbness in my hands; chronic fatigue; 1st dose 08May2021 / 2nd dose 22May2021; 1st dose 08May2021 / 2nd dose 22May2021; This is a spontaneous report received from a contactable consumer (patient). A 48-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 22May2021 11:00 (Batch/Lot Number: Unknown) (at the age of 48 years) as DOSE 2, SINGLE for covid-19 immunisation. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 administered in Arm Left on 08May2021 11:00 for covid-19 immunisation. Concomitant medications included multivitamins; ethinylestradiol, etonogestrel (NUVARING); both taken for an unspecified indication, start and stop date were not reported. The day after the second vaccine injection at 23May2021 08:00, patient had rapid heartbeat for 7 days. Upon an urgent care visit and an ekg (electrocardiogram), heart rate levels had returned to normal. After the heart episode, patient began having stroke like symptoms which she still has today. Patient's left eye has developed a blind spot, balance and coordination were compromised, speech and cognitive thinking was impaired, patient was now acutely light sensitive, sometimes there was numbness in hands and has chronic fatigue. Patient had an MRI (Magnetic resonance imaging) and several blood tests (unknown results). Patient's symptoms showed up the days after the 2nd Pfizer vaccine. No treatment was received for the events. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The events were reported as serious for disability. The outcome of event rapid heart beat was recovered on 30May2021, event 1st dose 08May2021 / 2nd dose 22May2021 was unknown, while for other events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. Results of tests and procedures for investigation of the patient: Test: Nasal Swab, Result: Negative, Date: 11Sep2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Heart palpitations, tachycardia, chest pain, ringing/whistling of left ear, pain at injection site with radiating pain down to left elbow and up into left side of neck.
EYES WENT CROSSED; PERSPIREING; FELT LIKE SHE WAS GOING  TO PASS OUT; VISION BECAME BLURRY/COULD NOT SEE; STOMACH WAS WOOZY; FELT A LITTLE OFF; This spontaneous report received from a patient concerned a 69 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced vision became blurry/could not see.  On APR-2021, the subject experienced stomach was woozy. On APR-2021, the subject experienced felt a little off.  On APR-2021, the subject experienced felt like she was going to pass out.  On 02-APR-2021, the subject experienced eyes went crossed.  On 02-APR-2021, the subject experienced perspireing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from perspireing, and the outcome of eyes went crossed, vision became blurry/could not see, stomach was woozy, felt a little off and felt like she was going to pass out was not reported. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard operating procedure as the case assessed as non-serious.
Reconstituted with sterile water instead of the liquid conjugate portion; Administered a dose of Menveo that had been reconstituted with sterile water; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA945A, expiry date 31-MAR-2025) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Reconstituted with sterile water instead of the liquid conjugate portion) and inappropriate dose of vaccine administered (Verbatim: Administered a dose of Menveo that had been reconstituted with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 21-JUN-2023 The reporter reported that the patient received Menveo vaccine which was reconstituted with sterile water instead of the liquid conjugate portion of the vaccine. The reporter wanted to remain anonymous. The reporter stated that two patients were given Menveo on that day and she did not know which patient received improperly reconstituted dose so she did not had patient information at the time of call. The reporter did consent to follow up via postal. Menveo reconstituted with sterile water instead of the supplied CYW-135 liquid conjugate, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
This report was received from a registered nurse refers to a male patient of unknown age who was in a non-merck investigator-initiated study. On an unspecified date, in August 2012, the patient was vaccinated with a doses of GARDASIL (lot number 660393/0067X) (dose and route not reported) that was expired 20-OCT-2010. No adverse effects had been observed or reported. Due to the nature of the study, the reporter declined to provide any patient identifiers. She would like to know if the patient should be revaccinated. Reporter called back on 16-OCT-2012 to stated that there was no additional information to provide, and she was not comfortable faxing these forms back. She requested that no additional follow-up forms or letters were sent to the office on this matter. This is one of several reports that received from the same source. Additional information is not expected.
Patient presented to the ED and was subsequently hospitalized for chest pain within 6 weeks of receiving COVID vaccination.
pneumonia; This is a spontaneous report from a sponsored program, received from a contactable consumer (patient). A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), on unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient said that she was supposed to receive the second dose of the PFIZER-BIONTECH COVID-19 VACCINE within an hour (17Apr2021). However, she said she had pneumonia and she wanted to know if her condition would have an impact to the vaccine. Patient said that she already got the first shot of the vaccine and she was scheduled to get the second dose the day of the present report (17Apr2021), however, she developed pneumonia. She would like to know if she should still get the vaccine today. She said that she wanted to get an answer right away. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Pt recv vax on 10/5/98; on same day pt exp pain, swelling of vax site then to shoulder, arm, wrist, hand; tight throat, left neck & left buttock pain; unable to move left arm; tx=Methylprednisolone (pt didn't take)
O20.0 - Threatened abortion PELVIC PAIN VAGINAL BLEEDING R07.89 - Other chest pain CHEST PAIN
This case was reported by a consumer via call center representative and described the occurrence of unable to walk in a elderly male patient who received SHINGRIX for prophylaxis. In October 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced unable to walk. On an unknown date, the outcome of the unable to walk was unknown. It was unknown if the reporter considered the unable to walk to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter reported the adverse event for his grandfather. The patient stated that the patient was given SHINGRIX, and since the injection, the patient had had lost the ability to walk on his own (a man who walked 2 miles a day prior to the injection). The reporter was curious if the company had any way to help them since it was this product that caused the issues. This case has been linked with case US2018GSK219943, reported by the same reporter.
Physician from a from another Pediatric facility inquired as to what immunization was given on 01/16/01. The patient presents today with 2 clusters of papules. The doctor said it was a local vaccine reaction. Treatment with Benadryl.
the day after the vaccination I started to get a quarter sized swelling in my left arm. Over the next 7-10 days, the swelling spread up to my shoulder and down to my elbow. The swelling was hot to the touch, red, itchy, tender, and about a quarter inch thick. Beyond that, I did not experience anything more than a day of fever and chills which I expected. I spoke with my  doctor who advised that I monitor the swelling and contact them if it spread to anywhere dangerous. But the swelling and other symptoms eventually went away on their own.
Vaccine on 2/13/01 (varivax). Hives began on 2/21/01 AM. Prelone was initiated on 2/23/01. D/t large response with arthralgias at this pt. Resolving quickly (skin and joints).
My comment is that I had the full blown side effect of "not being able to perform normal daily tasks for 2 days!" I had the fever, chills, nausea, total body aches and soreness. It was awful... my question is that I have to get the second dose in August and I don't want to be that sick again! My PCP says I might ......what do you think?? Is it effective if I just have the 1 dose? Thank you.
This event is reported since patient received the wrong vaccine type during 2nd dose. Patient received Moderna as 1st COVID vaccine dose at another facility on 3/18/21. On 4/13/21, patient came to our facility intending to receive 2nd dose Moderna, but inadvertently received Pfizer instead. There was no adverse event, this is reported since an error was made.
Vaccine administered BUD (on day 32); Vial was put in the fridge on 14Jun2021 and doses were administered on 16Jul2021 (on Day 32); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD (on day 32)) and PRODUCT STORAGE ERROR (Vial was put in the fridge on 14Jun2021 and doses were administered on 16Jul2021 (on Day 32)) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD (on day 32)) and PRODUCT STORAGE ERROR (Vial was put in the fridge on 14Jun2021 and doses were administered on 16Jul2021 (on Day 32)). On 16-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD (on day 32)) and PRODUCT STORAGE ERROR (Vial was put in the fridge on 14Jun2021 and doses were administered on 16Jul2021 (on Day 32)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow up received on 10-AUG-2021. contact information updated. On 02-Oct-2021: follow up received on 04-OCT-2021 contain information regarding first dose details.
Persistent headache, redness thruout entire deltoid,upper arm, "spells of lost time" on Monday", tiredness, malaise, severe soreness at injection site for days
A non-serious spontaneous report of administration of expired product was received from a health professional concerning a nine/ten-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 02-Feb-2011. The patient received the expired FLUMIST on 04-Feb-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. Additional information was received on 23-Mar-2011: Reporter confirmed that there was no late occurrence of adverse events.
1/07@1920 INJECTION RECEIVED 1/8 @ 1100 CHILLS BEGAN          @1130 102 FEVER RECORED; 1000MG ACETAMINOPHEN TAKEN          @1300 MIGRAIN BEGAN          @1700 NAUSEA BEGAN          @1900 CHEST PAIN STARTED          @2100 WENT TO THE ER
Extreme fatigue, low grade fever to 100.6, severe headache, joint pain. Symptoms lasted about 36 hours. Headache lasted beyond other symptoms.
12/6/2011 - redness, swelling golf ball size, ice was applied to the site. 12/08/2011 faint redness, swelling approx orange size.  Also complained of hot flashes and generalized itching, not at injection site.  MD prescribed Benadryl.
pt recv vax 1130AM & by 130PM pt was screaming per mom & that screaming episode lasted for 3hrs, mom did not phone in or did not bring pt in;
Extreme fatigue, chills, low fever, all over body aches, headache, numbness in all extremities, muscle spasms throughout my body.